Specify a stock or a cryptocurrency in the search bar to get a summary
Oncimmune Holdings plc
ONCOncimmune Holdings plc, a precision medicine company, provides autoantibody biomarker profiling in immuno-oncology, autoimmune, and infectious diseases in Europe and internationally. It offers ImmunoINSIGHTS, an autoantibody profiling service that unlocks the immune system to discover and convert autoantibodies into actionable biomarkers; Sero Tag, a discovery engine which identifies relevant biomarker pool for target discovery or companion diagnostics; NavigAID, a creation of a disease-specific biomarker panel; and Autoantibody Biomarkers, a companion diagnostic biomarker. The company also provides business development and marketing services. Oncimmune Holdings plc was incorporated in 2015 and is headquartered in Leeds, the United Kingdom. Address: 1 Park Row, Leeds, United Kingdom, LS1 5AB
Analytics
WallStreet Target Price
3 862.88 GBXP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ONC
Dividend Analytics ONC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ONC
Stock Valuation ONC
Financials ONC
Results | 2019 | Dynamics |